Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing
Open accessAbstract
The targeted deletion, replacement, integration or inversion of genomic sequences could be used to study or treat human genetic diseases, but existing methods typically require double-strand DNA breaks (DSBs) that lead to undesired consequences, including uncontrolled indel mixtures and chromosomal abnormalities. Here we describe twin prime editing (twinPE), a DSB-independent method that uses a prime editor protein and two prime editing guide RNAs (pegRNAs) for the programmable replacement or excision of DNA sequences at endogenous human genomic sites. The two pegRNAs template the synthesis of complementary DNA flaps on opposing strands of genomic DNA, which replace the endogenous DNA sequence between the prime-editor-induced nick sites. When combined with a site-specific serine recombinase, twinPE enabled targeted integration of gene-sized DNA plasmids (>5,000 bp) and targeted sequence inversions of 40 kb in human cells. TwinPE expands the capabilities of precision gene editing and might synergize with other tools for the correction or complementation of large or complex human pathogenic alleles.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
New prime editors have been developed to edit larger DNA sequences.
“Recently, new prime editors have been developed to edit larger DNA sequences.52”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247 · see citing works
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · see citing works
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184 · see citing works
Self-citationLong-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273 · see citing works
Regulation of DNA repair throughout the cell cycle
Branzei, D., & Foiani, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2351 · Cited by 1,228 · see citing works
The promise and challenge of therapeutic genome editing
Doudna, J. A. (2020) · Nature · doi:10.1038/s41586-020-1978-5 · Cited by 1,126 · see citing works
Regulation of Homologous Recombination in Eukaryotes
Heyer, W.-D., Ehmsen, K. T., & Liu, J. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-051710-150955 · Cited by 1,066 · see citing works
Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos
Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004832117 · Cited by 234 · see citing works
Gasperini, M., Findlay, G. M., McKenna, A., Milbank, J. H., Lee, C., Zhang, M. D., Cusanovich, D. A., & Shendure, J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.010 · Cited by 143 · see citing works
Flagged first, then by citations
Research works printed but not linked: 48
- [2]Landrum MJ ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42, D980– 985, doi: 10.1093/nar/gkt1113 (2014). 24234437 PMC3965032 · DOI · Paper page
- [3]Weischenfeldt J, Symmons O, Spitz F & Korbel JO Phenotypic impact of genomic structural variation: insights from and for human disease. Nat Rev Genet 14, 125– 138, doi: 10.1038/nrg3373 (2013). 23329113 · DOI
- [4]Cox DB, Platt RJ & Zhang F Therapeutic genome editing: prospects and challenges. Nat Med 21, 121– 131, doi: 10.1038/nm.3793 (2015). 25654603 PMC4492683 · DOI · Paper page
- [6]Anzalone AV, Koblan LW & Liu DR Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38, 824– 844, doi: 10.1038/s41587-020-0561-9 (2020). 32572269 · DOI · Paper page
- [9]Mali P RNA-guided human genome engineering via Cas9. Science 339, 823– 826, doi: 10.1126/science.1232033 (2013). 23287722 PMC3712628 · DOI · Paper page
- [12]Anzalone AV Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149– 157, doi: 10.1038/s41586-019-1711-4 (2019). 31634902 PMC6907074 · DOI · Paper page
- [13]Canver MC Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. The Journal of biological chemistry 289, 21312– 21324, doi: 10.1074/jbc.M114.564625 (2014). 24907273 PMC4118095 · DOI
- [14]Suzuki K In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature 540, 144– 149, doi: 10.1038/nature20565 (2016). 27851729 PMC5331785 · DOI · Paper page
- [15]Wang B Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes. Biotechniques 59, 201– 202, 204, 206-208, doi: 10.2144/000114339 (2015). 26458548 · DOI
- [16]Pawelczak KS, Gavande NS, VanderVere-Carozza PS & Turchi JJ Modulating DNA Repair Pathways to Improve Precision Genome Engineering. ACS Chem Biol 13, 389– 396, doi: 10.1021/acschembio.7b00777 (2018). 29210569 · DOI
- [20]Kosicki M, Tomberg K & Bradley A Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology 36, 765– 771, doi: 10.1038/nbt.4192 (2018). PMC6390938 30010673 · DOI · Paper page
- [22]Song Y Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System. Molecular Therapy - Nucleic Acids 21, 523– 526, doi: 10.1016/j.omtn.2020.06.019 (2020). 32711379 PMC7381496 · DOI
- [23]Brunet E & Jasin M Induction of Chromosomal Translocations with CRISPR-Cas9 and Other Nucleases: Understanding the Repair Mechanisms That Give Rise to Translocations. Advances in experimental medicine and biology 1044, 15– 25, doi: 10.1007/978-981-13-0593-1_2 (2018). 29956288 PMC6333474 · DOI
- [24]Nahmad AD Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage. bioRxiv, 2021.2008.2020.457092, doi: 10.1101/2021.08.20.457092 (2021). · DOI
- [25]Leibowitz ML Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing. Nature Genetics, doi: 10.1038/s41588-021-00838-7 (2021). PMC8192433 33846636 · DOI · Paper page
- [26]Haapaniemi E, Botla S, Persson J, Schmierer B & Taipale J CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. Nature Medicine 24, 927– 930, doi: 10.1038/s41591-018-0049-z (2018). 29892067 · DOI · Paper page
- [27]Ihry RJ p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells. Nature Medicine 24, 939– 946, doi: 10.1038/s41591-018-0050-6 (2018). 29892062 · DOI · Paper page
- [28]Enache OM Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat Genet 52, 662– 668, doi: 10.1038/s41588-020-0623-4 (2020). 32424350 PMC7343612 · DOI · Paper page
- [29]Merrick CA, Zhao J & Rosser SJ Serine Integrases: Advancing Synthetic Biology. ACS Synthetic Biology 7, 299– 310, doi: 10.1021/acssynbio.7b00308 (2018). 29316791 · DOI
- [30]Karpinski J Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat Biotechnol 34, 401– 409, doi: 10.1038/nbt.3467 (2016). 26900663 · DOI
- [31]Chaikind B, Bessen JL, Thompson DB, Hu JH & Liu DR A programmable Cas9-serine recombinase fusion protein that operates on DNA sequences in mammalian cells. Nucleic Acids Res 44, 9758– 9770, doi: 10.1093/nar/gkw707 (2016). 27515511 PMC5175349 · DOI
- [32]Gaj T Enhancing the Specificity of Recombinase-Mediated Genome Engineering through Dimer Interface Redesign. J Am Chem Soc 136, 5047– 5056, doi: 10.1021/ja4130059 (2014). 24611715 PMC3985937 · DOI
- [33]Kim AI Mycobacteriophage Bxb1 integrates into the Mycobacterium smegmatis groEL1 gene. Molecular Microbiology 50, 463– 473, doi: 10.1046/j.1365-2958.2003.03723.x (2003). 14617171 · DOI
- [34]Choi J Precise genomic deletions using paired prime editing. Nat Biotechnol, doi: 10.1038/s41587-021-01025-z (2021). PMC8847327 34650269 · DOI
- [35]Lin Q High-efficiency prime editing with optimized, paired pegRNAs in plants. Nature Biotechnology, doi: 10.1038/s41587-021-00868-w (2021). 33767395 · DOI · Paper page
- [36]Scriver CR The PAH gene, phenylketonuria, and a paradigm shift. Human Mutation 28, 831– 845, doi: 10.1002/humu.20526 (2007). 17443661 · DOI
- [37]Nelson JW Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol, doi: 10.1038/s41587-021-01039-7 (2021). PMC8930418 34608327 · DOI · Paper page
- [38]Flanigan KM Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Human mutation 30, 1657– 1666, doi: 10.1002/humu.21114 (2009). 19937601 PMC3404892 · DOI
- [39]Aartsma-Rus A Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues. Nucleic acid therapeutics 27, 251– 259, doi: 10.1089/nat.2017.0682 (2017). 28796573 PMC5649120 · DOI
- [40]Kim DY, Moon SB, Ko J-H, Kim Y-S & Kim D Unbiased investigation of specificities of prime editing systems in human cells. Nucleic Acids Research 48, 10576– 10589, doi: 10.1093/nar/gkaa764 (2020). 32941652 PMC7544197 · DOI
- [41]Jin S Genome-wide specificity of prime editors in plants. Nature Biotechnology, doi: 10.1038/s41587-021-00891-x (2021). 33859403 · DOI
- [42]Duportet X A platform for rapid prototyping of synthetic gene networks in mammalian cells. Nucleic acids research 42, 13440– 13451, doi: 10.1093/nar/gku1082 (2014) 25378321 PMC4245948 · DOI
- [43]Jusiak B Comparison of Integrases Identifies Bxb1-GA Mutant as the Most Efficient Site-Specific Integrase System in Mammalian Cells. ACS Synthetic Biology 8, 16– 24, doi: 10.1021/acssynbio.8b00089 (2019). 30609349 · DOI
- [44]Sharma R In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126, 1777– 1784, doi: 10.1182/blood-2014-12-615492 PMC4600017 26297739 · DOI · Paper page
- [46]Bessen JL High-resolution specificity profiling and off-target prediction for site-specific DNA recombinases. Nature Communications 10, 1937, doi: 10.1038/s41467-019-09987-0 (2019). PMC6486577 31028261 · DOI
- [47]Bondeson ML Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Human molecular genetics 4, 615– 621, doi: 10.1093/hmg/4.4.615 (1995). 7633410 · DOI
- [48]Chen X In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun 8, 657, doi: 10.1038/s41467-017-00687-1 (2017). 28939824 PMC5610252 · DOI
- [49]Park CY Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs. Proc Natl Acad Sci U S A 111, 9253– 9258, doi: 10.1073/pnas.1323941111 (2014). 24927536 PMC4078797 · DOI
- [50]Li J Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. Journal of molecular cell biology 7, 284– 298, doi: 10.1093/jmcb/mjv016 (2015). 25757625 PMC4524425 · DOI
- [1]Anzalone AV Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149– 157, doi: 10.1038/s41586-019-1711-4 (2019). 31634902 PMC6907074 · DOI · Paper page
- [2]Komor AC, Kim YB, Packer MS, Zuris JA & Liu DR Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420– 424, doi: 10.1038/nature17946 (2016). 27096365 PMC4873371 · DOI · Paper page
- [3]Clement K CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nature Biotechnology 37, 224– 226, doi: 10.1038/s41587-019-0032-3 (2019). PMC6533916 30809026 · DOI
- [4]Clement K, Farouni R, Bauer DE & Pinello L AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics 34, i202– i210, doi: 10.1093/bioinformatics/bty264 (2018). 29949956 PMC6022702 · DOI
- [5]Shen W, Le S, Li Y & Hu F SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation. PLoS One 11, e0163962, doi: 10.1371/journal.pone.0163962 (2016). 27706213 PMC5051824 · DOI · Paper page
- [6]Levy JM & Nicoll RA Membrane-associated guanylate kinase dynamics reveal regional and developmental specificity of synapse stability. The Journal of Physiology 595, 1699– 1709, doi: 10.1113/JP273147 (2017). 27861918 PMC5330878 · DOI
- [7]Koblan LW In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice. Nature 589, 608– 614, doi: 10.1038/s41586-020-03086-7 (2021). 33408413 PMC7872200 · DOI
- [8]Gaudelli NM Directed evolution of adenine base editors with increased activity and therapeutic application. Nature Biotechnology 38, 892– 900, doi: 10.1038/s41587-020-0491-6 (2020). 32284586 · DOI
- [9]Nelson JW Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol, doi: 10.1038/s41587-021-01039-7 (2021). PMC8930418 34608327 · DOI · Paper page
Cited by
Sorted by citations
Past, present, and future of CRISPR genome editing technologies
Pacesa, M., Pelea, O., & Jinek, M. (2024) · Cell · doi:10.1016/j.cell.2024.01.042 · Cited by 609 · see citing works
Designing and executing prime editing experiments in mammalian cells
Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J., & Liu, D. R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00724-4 · Cited by 172 · see citing works
Self-citationGenome editing and improvement of abiotic stress tolerance in crop plants
Yadav, R. K., Tripathi, M. K., Tiwari, S., Tripathi, N., Asati, R., Chauhan, S., Tiwari, P. N., & Payasi, D. K. (2023) · Life · doi:10.3390/life13071456 · Cited by 75 · see citing works
Directed evolution of hyperactive integrases for site specific insertion of transgenes
Hew, B. E., Gupta, S., Sato, R., Waller, D. F., Stoytchev, I., Short, J. E., Sharek, L., Tran, C. T., Badran, A. H., & Owens, J. B. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae534 · Cited by 35 · see citing works
Recent advances in prime editing technologies and their promises for therapeutic applications
Zeng, H., Daniel, T. C., Lingineni, A., Chee, K., Talloo, K., & Gao, X. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103071 · Cited by 27 · see citing works
Self-citationDevelopment and application of prime editing in plants
Tingting, L., Jinpeng, Z., Xi, Y., Kejian, W., Yuchun, R., & Chun, W. (2023) · Rice Science · doi:10.1016/j.rsci.2023.07.005 · Cited by 21 · see citing works
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17 · see citing works
Prime-editing methods and pegRNA design programs
Mikhaylova, E. V., Kuluev, B. R., Gerashchenkov, G. A., Chemeris, D. A., Garafutdinov, R. R., Kuluev, A. R., Baymiev, A. K., Baymiev, A. K., & Chemeris, A. V. (2024) · Molecular Biology · doi:10.1134/s0026893324010084 · Cited by 15 · see citing works
- Authors
- Anzalone, A. V., Gao, X. D., Podracky, C. J., Nelson, A. T., Koblan, L. W., Raguram, A., Levy, J. M., Mercer, J. A. M., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2021-12-09
- Volume
- 40
- Issue
- 5
- Pages
- 731-740
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC9117393
- OpenAlex
- W4200345742
- Cited by
- 613
- References
- 11
- Citations by year
- 2026: 129 · 2025: 143 · 2024: 141 · 2023: 128 · 2022: 71 · 2021: 1
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG00949)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01 AI142756)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- Howard Hughes Medical Institute (Liu investigatorship)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- prime editing, prime editors, pegRNA, serine recombinase
- MeSH terms
- Gene Editing, RNA, Guide, CRISPR-Cas Systems, Base Sequence, DNA, Humans, Chromosome Inversion, RNA, Guide, Kinetoplastida, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review